We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.105 | 2.26% | 4.755 | 4.52 | 4.99 | - | 189,060 | 16:35:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/8/2020 21:13 | Have we seen this world patent already? Apologies if already posted... | oranolio | |
07/8/2020 20:55 | Clearly this share could increase further. But most bank shares will double on a 2 to 3 year view. The problem here is all about when and whether a vaccine to Covid is discovered. What is the pharmaceuticals flow behind that? And as an investor, what is the likelihood of this being £4 in 2 years time or Lloyds being 50p. Lloyds will still be there! Now the Guild! Do not get sucked into the sublime experience of only posting to people who share your view! | bocker01 | |
07/8/2020 19:44 | I meant SNG!!! | scepticalinvestor | |
07/8/2020 19:12 | But whatever is going to happen, it needs to happen SOON, ideally before winter is upon us... | sloppyjoe2 | |
07/8/2020 19:10 | I'd hope for at least a couple of billion. Though of course whatever the treatment turns out to be 'worth', a licensing deal, JV etc will ensure that only a portion of the 'value' falls to SNG's bottom line. On the other hand a powerful pharma partner would have the marketing muscle and pricing power to maximise revenues... | sloppyjoe2 | |
07/8/2020 19:00 | I'm more than happy with 1 to 2 bn. But if it turns out higher I won't be complaining. | vikingwarrier | |
07/8/2020 18:39 | Going to need some solid news to propel us to such levels though: FDA fast-tracking, a licensing deal, a JV, a takeover, or some combination of those... | sloppyjoe2 | |
07/8/2020 18:37 | *and* SNG! | sloppyjoe2 | |
07/8/2020 18:16 | agreed - I have been a little cautious about covid stocks but out of all, SNY shows the most promise. | scepticalinvestor | |
07/8/2020 18:08 | c150m shares in issue, so a MC of £1bn is a share price of roughly 670p. So the question is, how much do we think, globally, a treatment for covid (to say nothing of other indications like COPD) is worth? £1bn? £5bn? 10? 20? | sloppyjoe2 | |
07/8/2020 17:53 | From a trading perspective it looks as thought 300p could be within sight soon. aimho | scepticalinvestor | |
07/8/2020 17:51 | just kidding! i bought in today too. | scepticalinvestor | |
07/8/2020 17:51 | enjoy your losses! | scepticalinvestor | |
07/8/2020 17:28 | About 2.5m late reported trades today. | wetdream | |
07/8/2020 17:07 | Expected to close higher today. Don't get me wrong, blue is always good, but I've been slightly disappointed at the lack of wider excitement around this share the past week or so. Let's hope for news next week, add another booster stage to the rocket... | sloppyjoe2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions